A phase IB/II, open-label, dose escalation study to evaluate the safety, pharmacokinetics, and efficacy of SM88 in patients with prostate cancer.

被引：0
|
作者：
Del Priore, Giuseppe
Hoffman, Steve
Nixon, Daniel W.
机构：
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷
关键词：
D O I：
10.1200/JCO.2017.35.15_suppl.TPS2615
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
TPS2615
引用
收藏
页数：6
相关论文
共 50 条
  • [1] Phase Ib pharmacokinetics of non-hormonal SM88 in patients with non-metastatic recurrent prostate cancer.
    Del Priore, Giuseppe
    Rothman, John
    Sokol, Gerald H.
    Hoffman, Karen
    Retter, Avi S.
    Hoffman, Steve
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [2] Open-label, phase I/II dose-escalation study of ARANESP™ in patients with chronic anemia of cancer.
    Glaspy, J
    Meza, L
    Smith, R
    Fleishman, A
    Mendes, E
    Colowick, A
    BLOOD, 2000, 96 (11) : 154B - 155B
  • [3] An open-label, phase Ib/II study to evaluate the safety and efficacy of fruquintinib in combination with tislelizumab in patients with advanced triple-negative breast cancer
    Tripathy, D.
    Ukrainskyj, S. M.
    Yang, Z.
    Kania, M.
    Schelman, W.
    Hamilton, E.
    ANNALS OF ONCOLOGY, 2021, 32 : S514 - S514
  • [4] Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration resistant prostate cancer in an open-label phase Ib study
    Rodriguez-Vida, A.
    Maroto Rey, J. P.
    Font Pous, A.
    Martin, C.
    Mellado, B.
    Corbera Lloret, A.
    Orrillo Sarmiento, M.
    Reig Torras, O.
    Querol Ninerola, R.
    Cano, L.
    Palazon, A.
    Alonso, J.
    Galtes, S.
    Juanpere, N.
    Juan, O.
    Bellmunt, J.
    ANNALS OF ONCOLOGY, 2021, 32 : S665 - S665
  • [5] A phase Ib open-label, dose escalation and expansion study to investigate the safety, pharmacokinetics, pharmacodynamics and clinical activity of GSK525762 in combination with abiraterone or enzalutamide in metastatic castrate-resistant prostate cancer.
    Vaishampayan, Ulka N.
    Narayan, Vivek
    Wise, David
    Lang, Joshua Michael
    Lowentritt, Benjamin H.
    Mellado, Begona
    Carles, Joan
    Saez, M. Isabel
    Abida, Wassim
    Taplin, Mary-Ellen
    Azad, Arun
    Wang, Karrie
    Barbash, Olena
    Ferron-Brady, Geraldine
    Fecteau, Doug
    Khaled, Ahmed Hussein
    Dhar, Arindam
    De Bono, Johann S.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (06)
  • [6] Phase 1/2a, open-label, dose-escalation and safety study of APC-100 in men with advanced prostate cancer.
    Kyriakopoulos, Christos
    Heath, Elisabeth I.
    Eickhoff, Jens C.
    Kolesar, Jill
    Yayehyirad, Mulusew
    Moll, Thomas
    Liu, Glenn
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
  • [7] Phase Ib/II open-label study to evaluate the safety, tolerability, and efficacy of rivoceranib plus trifluridine/tipiracil in patients with previously treated metastatic colorectal cancer
    Eng, C.
    Park, C. H.
    Meng, X.
    Jang, S. H.
    ANNALS OF ONCOLOGY, 2023, 34 : S453 - S454
  • [8] An open-label, multicenter, phase Ib/II study of rebastinib in combination with paclitaxel in a dose-expansion cohort to assess safety and preliminary efficacy in patients with advanced or metastatic endometrial cancer.
    Janku, Filip
    Hamilton, Erika Paige
    Chu, Christina
    Richardson, Debra L.
    Arend, Rebecca Christian
    Kuida, Keisuke
    Achour, Haroun
    Ruiz-Soto, Rodrigo
    Hays, John L.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [9] Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study
    Alejo Rodriguez-Vida
    Pablo Maroto
    Albert Font
    Cristina Martin
    Begoña Mellado
    Alex Corbera
    Mayra Orrillo
    Oscar Reig
    Rosa Querol
    Alejandro Rios-Hoyo
    Laia Cano
    Judith Alonso
    Gemma Martinez
    Susana Galtes
    Alvaro Taus
    Maria Martinez-Garcia
    Nuria Juanpere
    Oscar Juan
    Joaquim Bellmunt
    British Journal of Cancer, 2023, 128 : 21 - 29
  • [10] Safety and efficacy of avelumab plus carboplatin in patients with metastatic castration-resistant prostate cancer in an open-label Phase Ib study
    Rodriguez-Vida, Alejo
    Maroto, Pablo
    Font, Albert
    Martin, Cristina
    Mellado, Begona
    Corbera, Alex
    Orrillo, Mayra
    Reig, Oscar
    Querol, Rosa
    Rios-Hoyo, Alejandro
    Cano, Laia
    Alonso, Judith
    Martinez, Gemma
    Galtes, Susana
    Taus, Alvaro
    Martinez-Garcia, Maria
    Juanpere, Nuria
    Juan, Oscar
    Bellmunt, Joaquim
    BRITISH JOURNAL OF CANCER, 2023, 128 (01) : 21 - 29
12345